search
Back to results

Psychomotor Therapy as Complimentary Treatment to Patients With Shoulder Pain. (PsychShoP)

Primary Purpose

Shoulder Pain

Status
Completed
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
Psychomotor therapy
Physiotherapy
corticosteroid injection
Sponsored by
Vejle Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Shoulder Pain

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • >three months of should pain
  • Disturbed sleep due to shoulder pain
  • VAS resting pain above 2 OR VAS activity pain above 5
  • MAIA score <= 3
  • Read and understand Danish.

Exclusion Criteria:

  • Frozen shoulder
  • Glenohumeral (GH) arthritis
  • Rotator Cuff (RC) rupture
  • GH instability
  • Acromioclavicular joint arthritis
  • Operation in the shoulder joint within the last six months
  • Cervical problems
  • Psychiatric diagnosis
  • Alcohol or drug abuse

Sites / Locations

  • Shoulder clinic, Orthopedic department, Hospital Lillebaelt - Vejle Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Physiotherapy + Corticosteroid injection + Psychomotor therapy

Physiotherapy + Corticosteroid injection

Arm Description

Usual care + intervention

Usual care

Outcomes

Primary Outcome Measures

Patient reported function and pain on the "Disability in the Arm, Shoulder and Hand (DASH) questionnaire"
Patient reported generic shoulder outcome questionnaire (questions upon function and pain related limitations).

Secondary Outcome Measures

Hospital Anxiety and Depression score (HAD)
Patient reported generic mental outcome measure
Hospital Anxiety and Depression score (HAD)
Patient reported generic mental outcome measure
Pain on the NRS Scale
"Short Message Service" (SMS) is sent to the patients phone regarding pain.
Multidimensional Assessment of Interoceptive Awareness (MAIA)
Patient reported generic body awareness outcome measure
Multidimensional Assessment of Interoceptive Awareness (MAIA)
Patient reported generic body awareness outcome measure

Full Information

First Posted
November 24, 2015
Last Updated
November 1, 2017
Sponsor
Vejle Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT02629783
Brief Title
Psychomotor Therapy as Complimentary Treatment to Patients With Shoulder Pain.
Acronym
PsychShoP
Official Title
Psychomotor Therapy as Complimentary Treatment to Patients With Shoulder Pain - a Randomized Controlled Trial.
Study Type
Interventional

2. Study Status

Record Verification Date
November 2017
Overall Recruitment Status
Completed
Study Start Date
March 1, 2016 (Actual)
Primary Completion Date
September 1, 2017 (Actual)
Study Completion Date
September 1, 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Vejle Hospital

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Some patients with shoulder pain have decreased body awareness (BA). To some degree, pain among these patients can be increased due to their lack in BA. Psychomotor therapy is thought to improve BA and thereby increase the effect of traditional therapy, such as physiotherapy and exercises. The aim of this study is therefore to investigate if psychomotor therapy, as a complimenting treatment to physiotherapy, decreases shoulder patients' function deficits and pain reported on PRO's, compared to physiotherapy alone.
Detailed Description
Study design: This trial, is a randomised, controlled, observer-blinded superiority trial, with a two-group parallel design, to be conducted in Denmark. The primary endpoint will be 12 weeks after baseline. Patients will be randomised to either "Intervention+Usual Care" or "Usual Care" (block randomization with a 1:1 allocation). Settings and locations: Patients will be recruited from the shoulder unit at the outpatient clinic, orthopaedic department at Hospital Lillebaelt - Vejle Hospital. Randomisation and allocation concealment: Patients will be randomly assigned to either of the two groups with a 1:1 allocation as per a computergenerated randomisation schedule, stratified by administration of concomitant corticosteroid injection using permuted blocks of random sizes (two to six). The primary investigator, assessors and administrator of the randomisation procedure will not know block sizes in order to ensure allocation concealment Blinding: Outcome assessors will perform both baseline and followup assessments, and will be kept blinded from treatment allocation. At the follow-up assessments, patients will be strongly encouraged not to disclose the components of their intervention programme, in order to keep the outcome assessor blinded. Statistical analysis plan: The primary efficacy analysis performed is assessment of the between-group difference in change in the DASH score after 12 weeks in the intent-to-treat (ITT) population (all randomised patients independent of compliance and withdrawals). In the case of missing data due to dropouts, a non-responder imputation will be applied; a baseline observation carried forward (BOCF) technique will be used for patients who do not complete the study. For the primary analyses at week 12, we will use analysis of covariance (ANCOVA) to compare the progressive high-load exercise group with the low-load exercise group for mean changes from baseline in the DASH score, as well as the secondary continuous outcomes. The primary model includes the change from baseline as the dependent variable, with treatment group (Intervention OR Usual care), corticosteroid status (yes or no) as main effects, with the baseline score as an additional covariate. To analyse the longitudinal element of time effects of NRS in the randomized trial (repeated measures design 1-24 weeks), a linear approach will be used, fitted in SAS software (version 9.3 Service Pack 4; SAS Institute Inc., Cary, North Carolina, United States) using the procedure 'PROC MIXED' based on restricted maximum likelihood (REML) estimates of the parameters. The variable 'patient' will be applied as a random effects factor. Assessment of the treatment and time effects is of exploratory interest for the primary outcome in testing for a possible interaction, and both treatment and time will be used as systematic factors, using the baseline value as covariate to reduce random variation and increase power.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Shoulder Pain

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
InvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
88 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Physiotherapy + Corticosteroid injection + Psychomotor therapy
Arm Type
Experimental
Arm Description
Usual care + intervention
Arm Title
Physiotherapy + Corticosteroid injection
Arm Type
Active Comparator
Arm Description
Usual care
Intervention Type
Other
Intervention Name(s)
Psychomotor therapy
Intervention Description
1 treatment of approximately 45 minutes the first 5 weeks after randomization. The treatment will focus on teaching the patients about body awareness and handling of there shoulder problems in daily living.
Intervention Type
Other
Intervention Name(s)
Physiotherapy
Intervention Description
Patients are, in secondary care setting, given 3-5 basic physiotherapy exercises for there shoulder pain, targeting rotator cuff muscles and scapula thoracic muscles. Furthermore they are given advice on seeking further physiotherapy guidance in private setting.
Intervention Type
Drug
Intervention Name(s)
corticosteroid injection
Intervention Description
At baseline, patients with signs of inflammation in the subacromial bursa, can receive a ultrasound guided corticosteroid injection in the bursa
Primary Outcome Measure Information:
Title
Patient reported function and pain on the "Disability in the Arm, Shoulder and Hand (DASH) questionnaire"
Description
Patient reported generic shoulder outcome questionnaire (questions upon function and pain related limitations).
Time Frame
Change from baseline DASH at 12 weeks
Secondary Outcome Measure Information:
Title
Hospital Anxiety and Depression score (HAD)
Description
Patient reported generic mental outcome measure
Time Frame
Change from baseline HAD at 12 weeks
Title
Hospital Anxiety and Depression score (HAD)
Description
Patient reported generic mental outcome measure
Time Frame
Change from baseline HAD at 24 weeks
Title
Pain on the NRS Scale
Description
"Short Message Service" (SMS) is sent to the patients phone regarding pain.
Time Frame
Change from baseline NRS at weeks 1-24
Title
Multidimensional Assessment of Interoceptive Awareness (MAIA)
Description
Patient reported generic body awareness outcome measure
Time Frame
Change from baseline MAIA at 12 weeks
Title
Multidimensional Assessment of Interoceptive Awareness (MAIA)
Description
Patient reported generic body awareness outcome measure
Time Frame
Change from baseline MAIA at 24 weeks
Other Pre-specified Outcome Measures:
Title
Quality of life on "EQ-5D"
Description
Patient reported generic quality of life outcome measure
Time Frame
Change from baseline EQ-5D at 12 weeks
Title
Quality of life on "EQ-5D"
Description
Patient reported generic quality of life outcome measure
Time Frame
Change from baseline EQ-5D at 24 weeks
Title
Patient reported function and pain on the "Disability in the Arm, Shoulder and Hand (DASH) questionnaire"
Description
Patient reported generic shoulder outcome questionnaire (questions upon function and pain related limitations).
Time Frame
Change from baseline DASH at 24 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: >three months of should pain Disturbed sleep due to shoulder pain VAS resting pain above 2 OR VAS activity pain above 5 MAIA score <= 3 Read and understand Danish. Exclusion Criteria: Frozen shoulder Glenohumeral (GH) arthritis Rotator Cuff (RC) rupture GH instability Acromioclavicular joint arthritis Operation in the shoulder joint within the last six months Cervical problems Psychiatric diagnosis Alcohol or drug abuse
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Lilli Soerensen, MD
Organizational Affiliation
Outpatient shoulder clinic, orthopaedic department at Hospital Lillebaelt - Vejle Hospital
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Kim G. Ingwersen, PhD.Fellow
Organizational Affiliation
Rehabilitation department at Hospital Lillebaelt - Vejle Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Shoulder clinic, Orthopedic department, Hospital Lillebaelt - Vejle Hospital
City
Vejle
State/Province
Jutland
ZIP/Postal Code
7000
Country
Denmark

12. IPD Sharing Statement

Citations:
PubMed Identifier
31247165
Citation
Ingwersen KG, Vobbe JW, Pedersen LL, Sorensen L, Wedderkopp N. Effect of Psychomotricity in Combination With 3 Months of Active Shoulder Exercises in Individuals With Chronic Shoulder Pain: Primary Results From an Investigator-Blinded, Randomized, Controlled Trial. Arch Phys Med Rehabil. 2019 Nov;100(11):2136-2143. doi: 10.1016/j.apmr.2019.05.032. Epub 2019 Jun 24.
Results Reference
derived

Learn more about this trial

Psychomotor Therapy as Complimentary Treatment to Patients With Shoulder Pain.

We'll reach out to this number within 24 hrs